Cryoport Inc (CYRX) Stock Price, Quote & News

Company Profile

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry. Its Life Sciences Products segment offers cryogenic freezers, cryogenic dewars, and accessories within the life science industry through direct sales or a distribution network. The company's products inc...

Industry: Integrated Freight & Logistics

Sector: Industrials

Phone: 949 470 2300

Website: www.cryoportinc.com

Address:

112 Westwood Place, Suite 350, Brentwood, United States

agamemnus Nov. 14 at 8:00 PM

$CYRX ZERO buying!!!

0 · Reply

agamemnus Nov. 14 at 7:18 PM

$CYRX DEAD AS A DOORNAIL

0 · Reply

agamemnus Nov. 14 at 7:04 PM

$CYRX Wow it is up 200% more than 30 seconds ago... up three cents!!

0 · Reply

agamemnus Nov. 14 at 7:03 PM

$CYRX R u kidding me? Up 1 cent?

0 · Reply

agamemnus Nov. 14 at 1:01 PM

$CYRX $9.30+ today. Needs volume.

0 · Reply

agamemnus Nov. 13 at 1:01 PM

$CYRX completely dead stock.. no idea why it's not trading over $10 already.

0 · Reply

BillionerOfKing Nov. 13 at 12:16 PM

$CYRX Current Stock Price: $8.83 Contracts to trade: $10 CYRX Nov 21 2025 Call Entry: $0.09 Exit: $0.16 ROI: 82% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

d_risk Nov. 6 at 8:06 PM

$CYRX - CryoPort Inc. Common Stock - 10Q - Updated Risk Factors CYRX warns that an ongoing U.S. federal government shutdown could significantly disrupt its operations and financial results. #Biotechnology #RegulatoryEnvironment #FinancialImpact #OperationalRisk #GovernmentShutdown 🟢 Added 🟠 Removed https://d-risk.ai/CYRX/10-Q/2025-11-06

0 · Reply

agamemnus Nov. 6 at 10:36 AM

$CYRX $SRPT I'm sorry but the move yesterday was insane and wrong for CYRX - meanwhile a (probably) big customer of theirs recovers huge on their own huge inappropriate selloff (SRPT). The stock was recently over $10.70 and people or algos panic sold it or under $9. Now earnings come out and they beat revenue, net income, and guidance. And it drops another 7.5% on low volume. It should have rallied 15-25%. What i think happened is that some retail stops got hit and algos goes into that and created an artificial pattern. Meanwhile the algos that were supposed to buy in based on the triple beat saw the chart and decided to wait for the slaughter to end. Now you have some algos that are holding short for the next few days and some algos in reserve. One algo covered towards the end of the day. All it took was maybe a few tens of thousand shares to get their stop losses hit for algos to ignore the earnings and create a chain reaction. This should be over $11.

0 · Reply

nikitatrades Nov. 6 at 12:54 AM

Needham Reiterates BUY on $CYRX 🚀 Raises Price Target to $12 (from $11) Why the raise? ✅ Q3 Revenue Beat & raised 2025 guidance. ✅ Sees potential upside to 2026 estimates. ✅ On track for adjusted EBITDA profitability as soon as Q4 2025. Continued execution strength supports the bullish view.

0 · Reply

Cryoport Systems Wins 2025 BioTech Breakthrough Award For “BioServices Innovation of the Year”

Nov 4, 2025, 11:56 PM EST - 9 days ago

Cryoport, Inc. (CYRX) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 4:21 PM EST - 10 days ago

Cryoport Reports Strong Q3 Results, Raises FY25 Outlook

Nov 4, 2025, 4:05 PM EST - 10 days ago

Cryoport Reports Third Quarter 2025 Financial Results

Oct 30, 2025, 8:30 AM EDT - 15 days ago

Cryoport Continues to Set New Benchmarks for the Global Regenerative Medicine Supply Chain

Oct 21, 2025, 8:00 AM EDT - 24 days ago

Cryoport to Report Third Quarter 2025 Financial Results on November 4, 2025

Oct 7, 2025, 8:30 AM EDT - 5 weeks ago

MVE Biological Solutions, A Cryoport Company, Introduces Real-Time Integrated Condition Monitoring Systems For Cryogenic Dewars

Oct 1, 2025, 8:30 AM EDT - 6 weeks ago

Cryoport Systems Expands Global Footprint with New Global Supply Chain Center in Paris, France

Aug 5, 2025, 8:05 PM EDT - 3 months ago

Cryoport, Inc. (CYRX) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 4:19 PM EDT - 3 months ago

Cryoport Reports Second Quarter 2025 Financial Results

Jul 22, 2025, 8:00 AM EDT - 4 months ago

Cryoport to Report Second Quarter 2025 Financial Results on August 5, 2025

Jul 8, 2025, 8:00 AM EDT - 4 months ago

Cryoport's MVE Biological Solutions Introduces Next Generation Vapor Shippers

Jun 12, 2025, 8:00 AM EDT - 5 months ago

Cryoport Completes CRYOPDP Divestiture and Commences Strategic Partnership with DHL Group

May 7, 2025, 7:15 PM EDT - 6 months ago

Cryoport, Inc. (CYRX) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:05 PM EDT - 6 months ago

Cryoport Reports First Quarter 2025 Financial Results

Apr 24, 2025, 8:30 AM EDT - 7 months ago

Cryoport to Report First Quarter 2025 Financial Results on May 7, 2025

Mar 31, 2025, 3:11 PM EDT - 8 months ago

Cryoport, Inc. (CYRX) Strategic Agreement and Transaction with DHL Group Call (Transcript)

Mar 31, 2025, 9:06 AM EDT - 8 months ago

DHL Group acquires CRYOPDP from Cryoport to strengthen "DHL Health Logistics"

Mar 31, 2025, 8:09 AM EDT - 8 months ago

Cryoport to Host Investor Call to Discuss Recent Strategic Agreement and Transformative Transaction Today, March 31, 2025, at 8:30 a.m. ET

Mar 12, 2025, 8:30 AM EDT - 8 months ago

Cryoport's MVE Biological Solutions Expands High-Efficiency Cryogenic Freezer Series With Answer to Evolving Needs of Fertility Clinics, Biorepositories and Clinical Laboratories

Mar 4, 2025, 8:41 PM EST - 9 months ago

Cryoport, Inc. (CYRX) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 4:10 PM EST - 9 months ago

Cryoport Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 18, 2025, 8:30 AM EST - 9 months ago

Cryoport to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

Jan 21, 2025, 8:30 AM EST - 10 months ago

Cryoport Unveils State-of-the-Art Cryogenic Shipping System for Transporting Lifesaving Biologics and Temperature-Sensitive Therapies

Jan 14, 2025, 8:30 AM EST - 10 months ago

Moffitt Cancer Center and Cryoport Announce Strategic Collaboration

Jan 6, 2025, 8:30 AM EST - 11 months ago

Cryoport's MVE Biological Solutions Registers All Manufacturing Facilities with the U.S. Food and Drug Administration ("FDA")

Nov 24, 2024, 11:51 PM EST - 1 year ago

Cryoport Remains A Disappointing Prospect

Nov 12, 2024, 8:30 AM EST - 1 year ago

Cryoport Expands IntegriCell™ Cryopreservation Services Solution with Opening of New Center of Excellence in Europe

Nov 9, 2024, 4:54 AM EST - 1 year ago

Cryoport, Inc. (CYRX) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 1 year ago

Cryoport Reports Third Quarter 2024 Financial Results

Oct 29, 2024, 8:30 AM EDT - 1 year ago

Cryoport to Report Third Quarter 2024 Financial Results on November 7, 2024

Oct 22, 2024, 8:30 AM EDT - 1 year ago

Cryoport and Gulf Coast Regional Blood Center Launch Strategic Alliance to Enhance Cellular Therapy Services

Oct 21, 2024, 8:30 AM EDT - 1 year ago

TMRW Life Sciences and Cryoport Systems Form Strategic Partnership to Elevate Standards for Frozen Egg, Embryo, and Sperm Offsite Storage and Biologistics

Oct 15, 2024, 8:30 AM EDT - 1 year ago

VGXI Selects Cryoport for Biostorage, Bioservices and Supply Chain Solutions to Advance Next-Generation Therapies

Oct 7, 2024, 8:30 AM EDT - 1 year ago

Cryoport Launches its IntegriCell™ Cryopreservation Solution with Opening of New Facility at its Houston Campus

Sep 25, 2024, 8:30 AM EDT - 1 year ago

SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices

Aug 22, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Inquiring Into Possible Securities Fraud By Cryoport Inc And Shareholders Are Encouraged To Reach Out

Aug 17, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Investigating Cryoport Inc And Asks Investors To Reach Out

Aug 16, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Begins Investigation Into Cryoport Inc And Asks Shareholders To Reach Out

Aug 15, 2024, 7:00 PM EDT - 1 year ago

The Schall Law Firm Opens Investigation Into Cryoport Inc And Encourages Shareholders To Reach Out

Aug 14, 2024, 10:15 PM EDT - 1 year ago

The Schall Law Firm Initiates Investigation Into Claims Against Cryoport Inc And Urges Shareholders To Reach Out

Aug 13, 2024, 11:15 PM EDT - 1 year ago

The Schall Law Firm Initiates Probe Into Allegations Against Cryoport Inc And Motivates Its Shareholders To Contact

Aug 12, 2024, 8:00 PM EDT - 1 year ago

The Schall Law Firm Begins Investigation Into Claims Against Cryoport Inc And Encourages Its Shareholders To Reach Out

Aug 9, 2024, 8:00 PM EDT - 1 year ago

The Schall Law Firm Initiates Investigation Into Claims Against Cryoport Inc And Urges Its Shareholders To Contact

Aug 8, 2024, 8:30 PM EDT - 1 year ago

The Schall Law Firm Begins Probe Into Allegations Against Cryoport Inc And Encourages Its Shareholders To Reach Out

Aug 7, 2024, 5:45 PM EDT - 1 year ago

The Schall Law Firm Initiates Investigation Into Claims Against Cryoport Inc And Urges Its Shareholders To Get In Touch

agamemnus Nov. 14 at 8:00 PM

$CYRX ZERO buying!!!

0 · Reply

agamemnus Nov. 14 at 7:18 PM

$CYRX DEAD AS A DOORNAIL

0 · Reply

agamemnus Nov. 14 at 7:04 PM

$CYRX Wow it is up 200% more than 30 seconds ago... up three cents!!

0 · Reply

agamemnus Nov. 14 at 7:03 PM

$CYRX R u kidding me? Up 1 cent?

0 · Reply

agamemnus Nov. 14 at 1:01 PM

$CYRX $9.30+ today. Needs volume.

0 · Reply

agamemnus Nov. 13 at 1:01 PM

$CYRX completely dead stock.. no idea why it's not trading over $10 already.

0 · Reply

BillionerOfKing Nov. 13 at 12:16 PM

0 · Reply

d_risk Nov. 6 at 8:06 PM

0 · Reply

agamemnus Nov. 6 at 10:36 AM

0 · Reply

nikitatrades Nov. 6 at 12:54 AM

0 · Reply

JarvisFlow Nov. 5 at 11:25 PM

UBS has updated their rating for CryoPort ( $CYRX ) to Buy with a price target of 12.5.

0 · Reply

1DayAtAtime63 Nov. 5 at 8:35 PM

$CYRX My sentiment also! 3rd qtr report was one of their BEST ever. $2.2 mil cash flow positive! Beating estimates!

1 · Reply

agamemnus Nov. 5 at 6:08 PM

$CYRX WTF? Also, where is everyone?

0 · Reply

erevnon Nov. 5 at 12:04 PM

Needham maintains CryoPort $CYRX https://marketsblock.com/stock-upgrades-and-downgrades/at Buy and raises the price target from $11 to

0 · Reply

Thestocktraderhubzee Nov. 5 at 11:19 AM

WATCHLIST NOV 05 2025 $NUVL Nuvalent To Present Patient-Reported Outcomes Data From The Phase 2 Portion Of The ARROS-1 Phase 1/2 Clinical Trial Of Zidesamtinib And Encore Pivotal Efficacy And Safety Data From The ARROS-1 Trial At 2025 IASLC ASCO North America Conference On Lung Cancer $TNYA Tenaya Therapeutics To Give Two Late-breaking Oral Presentations At The American Heart Association 2025 Scientific Sessions Taking Place November 7-10, 2025 $RIGL Rigel Pharmaceuticals shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 sales guidance above estimates. $CYRX Needham Maintains Buy on CryoPort, Raises Price Target to $12 $NVO Novo Nordisk CEO Says Company Expanding Telehealth For Obesity Care, Confident In Pipeline But Seeking More Candidates; CFO Notes Growth Deceleration Toward Year-End

0 · Reply

JarvisFlow Nov. 5 at 11:06 AM

Needham has adjusted their stance on CryoPort ( $CYRX ), setting the rating to Buy with a target price of 11 → 12.

0 · Reply

agamemnus Nov. 4 at 10:44 PM

$CYRX steady progress... the move down last week was unwarranted.

0 · Reply

R33dh Nov. 4 at 8:15 PM

$CYRX in for a swing! 8.76

0 · Reply

PonziBuddy2035 Oct. 30 at 1:34 AM

$CYRX $AMD $INTC

2 · Reply

agamemnus Oct. 28 at 8:45 PM

$CYRX I didn't see the 10/21 pr but I will think it sounds a little hinky. IDK WTF happened today tbh. Can only guess.

1 · Reply

R33dh Oct. 28 at 7:49 PM

$CYRX wtf?

0 · Reply

agamemnus Oct. 28 at 2:20 PM

$CYRX Hinky sounding press release. That is why it is down.

3 · Reply

Market Cap	442.11M
Revenue (ttm)	228.39M
Net Income (ttm)	-114.76M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-50.25%
Debt to Equity Ratio	0.36

Volume	464,000
Avg Vol	709,210
Day's Range	N/A - N/A
Shares Out	50.07M
Stochastic %K	43%
Beta	1.58
Analysts	Strong Sell
Price Target	$13.22